|
Generic Name : Gefitinib
Pronunciation : geh-FIT-in-ib
Therapeutic Classification : Chemotherapy
ICD Code : Y43.3
Therapeutic Classification : Chemotherapy Trade Name(s): India- Chemofit, Gefitec, Gefitero, Gefonib, Geftib, Geftilon, Geftinat. International- Iressa. Why it is prescribed (Indications) : This medication is a chemotherapy agent, prescribed for non-small cell lung cancer. It blocks the action of a certain substance that may be needed for cancer cell multiplication. When it is not to be taken (Contraindications): Hypersensitivity.
Dosage & When it is to be taken : Adult- PO- The recommended daily dose is one 250 mg. How it should be taken : It comes as a tablet to take by mouth, with or without food. Warnings and Precautions : * Caution should be exercised in patients with history of lung disease, heart, kidney, or liver problems; any allergy, who are taking other medications, during pregnancy and breastfeeding. * It may cause changes in vision, do not drive a car or operate machinery while taking this medication. Side Effects : Diarrhea, rash, pimples, dry skin, nausea, vomiting, itching, loss of appetite, weakness and weight loss. * Avoid excess dosage. Storage Conditions : Store it at controlled room temperature (20-25°C). |
![]() Comment & Contribute
![]()
![]() ![]() | ||




Ask an Expert